JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 7 1155-1162
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kogure, D.
Right arrow Articles by Takasaki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kogure, D.
Right arrow Articles by Takasaki, M.

Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion SPECT

Daiji Kogure, Hiroshi Matsuda, Takashi Ohnishi, Takashi Asada, Masatake Uno, Toshiyuki Kunihiro, Seigo Nakano and Masaru Takasaki

Departments of Radiology, Psychiatry, and Geriatric Medicine, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center of Neurology and Psychiatry, Tokyo
Department of Geriatric Medicine, Tokyo Medical University, Tokyo, Japan

Correspondence: For correspondence or reprints contact: Hiroshi Matsuda, MD, Department of Radiology, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center of Neurology and Psychiatry, 4-1 -1, Ogawahigashi, Kodaira, Tokyo, 187-8551, Japan.

ABSTRACT

The aim of this SPECT study was to determine the initial abnormality and longitudinal changes in regional cerebral blood flow (rCBF) in early Alzheimer's disease (AD) using statistical parametric mapping (SPM). Methods: rCBF was noninvasively measured using 99mTc-ethyl cysteinate dimer SPECT in 32 patients complaining of mild cognitive impairment, with a Mini-Mental State Examination score more than 24 at the initial study, and 45 age-matched healthy volunteers. All patients satisfied the diagnostic criteria of AD during the follow-up period of at least 2 y. Follow-up SPECT studies were performed on the patients at a mean interval of 15 mo. We used the raw data (absolute rCBF parametric maps) and the adjusted rCBF images of relative flow distribution (normalization of global cerebral blood flow [CBF] for each subject to 50 mL/100 g/min with proportional scaling) to compare these groups with SPM. Results: In the baseline study, the adjusted rCBF was significantly and bilaterally decreased in the posterior cingulate gyri and precunei of patients compared with healthy volunteers. In the follow-up study, selected reduction of the adjusted rCBF was observed in the left hippocampus and parahippocampal gyrus. These areas showed the most prominent reduction in absolute rCBF on each occasion. Moreover, further decline of the absolute rCBF was longitudinally observed in extensive areas of the cerebral association cortex. Conclusion: SPM analysis showed the characteristic early-AD rCBF pattern of selective decrease and longitudinal decline, which may be overlooked by a conventional region-of-interest technique with observer a priori choice and hypothesis. This alteration in rCBF may closely relate to the pathophysiologic process of this disease.

Key Words: Alzheimer's disease • SPECT • regional cerebral blood flow • statistical parametric mapping




This article has been cited by other articles:


Home page
JNMHome page
J. Sojkova, L. Beason-Held, Y. Zhou, Y. An, M. A. Kraut, W. Ye, L. Ferrucci, C. A. Mathis, W. E. Klunk, D. F. Wong, et al.
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
J. Nucl. Med., September 1, 2008; 49(9): 1465 - 1471.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
M. Pihlajamaki, K. M. DePeau, D. Blacker, and R. A. Sperling
Impaired Medial Temporal Repetition Suppression is Related to Failure of Parietal Deactivation in Alzheimer Disease
Am J Geriatr Psychiatry, April 1, 2008; 16(4): 283 - 292.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K.-J. Bar, M. K. Boettger, N. Seidler, H. J. Mentzel, C. Terborg, and H. Sauer
Influence of Galantamine on Vasomotor Reactivity in Alzheimer's Disease and Vascular Dementia Due to Cerebral Microangiopathy
Stroke, December 1, 2007; 38(12): 3186 - 3192.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
N SCHUFF and X P ZHU
Imaging of mild cognitive impairment and early dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S109 - S114.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. C. Johnson, M. L. Ries, T. M. Hess, C. M. Carlsson, C. E. Gleason, A. L. Alexander, H. A. Rowley, S. Asthana, and M. A. Sager
Effect of Alzheimer Disease Risk on Brain Function During Self-appraisal in Healthy Middle-aged Adults
Arch Gen Psychiatry, October 1, 2007; 64(10): 1163 - 1171.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Matsuda
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
J. Nucl. Med., August 1, 2007; 48(8): 1289 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Matsuda, S. Mizumura, T. Nagao, T. Ota, T. Iizuka, K. Nemoto, N. Takemura, H. Arai, and A. Homma
Automated Discrimination Between Very Early Alzheimer Disease and Controls Using an Easy Z-Score Imaging System for Multicenter Brain Perfusion Single-Photon Emission Tomography
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 731 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K A Johnson, E K Moran, J A Becker, D Blacker, A J Fischman, and M S Albert
Single photon emission computed tomography perfusion differences in mild cognitive impairment
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
A. Marcos, P. Gil, A. Barabash, R. Rodriguez, M. Encinas, C. Fernandez, and J. A. Cabranes
Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 189 - 196.
[Abstract] [PDF]


Home page
JNMHome page
W. P. Chen, I. Matsunari, A. Noda, D. Yanase, K. Yajima, N. Takeda, M. Yamada, S. Minoshima, and S. Nishimura
Rapid Scanning Protocol for Brain 18F-FDG PET: A Validation Study
J. Nucl. Med., October 1, 2005; 46(10): 1633 - 1641.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Kim, S. S. Cho, Y. Jeong, K. C. Park, S. J. Kang, E. Kang, S. E. Kim, K. H. Lee, and D. L. Na
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients
Brain, August 1, 2005; 128(8): 1790 - 1801.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
N. A. Johnson, G.-H. Jahng, M. W. Weiner, B. L. Miller, H. C. Chui, W. J. Jagust, M. L. Gorno-Tempini, and N. Schuff
Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience
Radiology, March 1, 2005; 234(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Mosconi, D. Perani, S. Sorbi, K. Herholz, B. Nacmias, V. Holthoff, E. Salmon, J.-C. Baron, M. T.R. De Cristofaro, A. Padovani, et al.
MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
Neurology, December 28, 2004; 63(12): 2332 - 2340.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Hirono, M. Hashimoto, K. Ishii, H. Kazui, and E. Mori
One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Imabayashi, H. Matsuda, T. Asada, T. Ohnishi, S. Sakamoto, S. Nakano, and T. Inoue
Superiority of 3-Dimensional Stereotactic Surface Projection Analysis over Visual Inspection in Discrimination of Patients with Very Early Alzheimer's Disease from Controls Using Brain Perfusion SPECT
J. Nucl. Med., September 1, 2004; 45(9): 1450 - 1457.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. A. Lambon Ralph, K. Patterson, N. Graham, K. Dawson, and J. R. Hodges
Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases
Brain, November 1, 2003; 126(11): 2350 - 2362.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, K. Berkouk, B. Landeau, C. Lalevee, F. Le Doze, B. Dupuy, D. Hannequin, et al.
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Brain, September 1, 2003; 126(9): 1955 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Yoshikawa, K. Murase, N. Oku, M. Imaizumi, M. Takasawa, P. Rishu, Y. Kimura, Y. Ikejiri, K. Kitagawa, M. Hori, et al.
Heterogeneity of Cerebral Blood Flow in Alzheimer Disease and Vascular Dementia
AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1341 - 1347.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, F. Eustache, and J.-C. Baron
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
Neurology, April 22, 2003; 60(8): 1374 - 1377.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G E J Garrido, S S Furuie, C A Buchpiguel, C M C Bottino, O P Almeida, C G Cid, C H P Camargo, C C Castro, M F Glabus, and G F Busatto
Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study
J. Neurol. Neurosurg. Psychiatry, November 1, 2002; 73(5): 508 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
X. M. Zheng
Detecting Regional Cerebral Blood Flow Changes in Alzheimer's Patients After Milameline Treatment: Activation or Baseline SPECT?
J. Nucl. Med. Technol., September 1, 2002; 30(3): 118 - 122.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. Nobili, M. Koulibaly, P. Vitali, O. Migneco, G. Mariani, K. Ebmeier, A. Pupi, P. H. Robert, G. Rodriguez, and J. Darcourt
Brain Perfusion Follow-Up in Alzheimer's Patients During Treatment with Acetylcholinesterase Inhibitors
J. Nucl. Med., August 1, 2002; 43(8): 983 - 990.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.C. de la Torre
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
Stroke, April 1, 2002; 33(4): 1152 - 1162.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Matsuda, N. Kitayama, T. Ohnishi, T. Asada, S. Nakano, S. Sakamoto, E. Imabayashi, and A. Katoh
Longitudinal Evaluation of Both Morphologic and Functional Changes in the Same Individuals with Alzheimer's Disease
J. Nucl. Med., March 1, 2002; 43(3): 304 - 311.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Herholz, H. Schopphoff, M. Schmidt, R. Mielke, W. Eschner, K. Scheidhauer, H. Schicha, W.-D. Heiss, and K. Ebmeier
Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer's Disease
J. Nucl. Med., January 1, 2002; 43(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T. Ohnishi, H. Matsuda, T. Tabira, T. Asada, and M. Uno
Changes in Brain Morphology in Alzheimer Disease and Normal Aging: Is Alzheimer Disease an Exaggerated Aging Process?
AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1680 - 1685.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Valla, J. D. Berndt, and F. Gonzalez-Lima
Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration
J. Neurosci., July 1, 2001; 21(13): 4923 - 4930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.